Partnering with NHS in a crisis: The role for industry

The impact of the pandemic has added extra pressure onto an NHS system that was already facing challenges due to limitations on resources and budgets. For an NHS in crisis, there has never been a better opportunity for the pharmaceutical industry to implement new partnership models that can help deliver better outcomes for patients.

However, such collaboration is nowhere near where it needs to be and there is an urgent need to align around priorities and ambitions on both sides, plus to translate the needs and objectives of both the NHS and industry to find common ground for engagement.

In this interactive webinar, brought to you by IQVIA, we will explore the critical role for mutually beneficial partnership between the pharmaceutical industry and the NHS in helping to deliver better outcomes for patients, especially as critical efficiencies need to be identified in the wake of this global pandemic.

Join us on Wednesday 15th March at 12:30pm GMT / 07:30am ET / 13:30pm CET as representatives from industry and NHS as well as subject-matter experts from IQVIA and pharmaphorum, dig into this important challenge.

The webinar will also explore:

• Objectives and priorities for industry-NHS collaboration
• Barriers to communication and collaboration
• The political, economic and social value propositions for NHS and industry
• The potential of technological solutions like real-world evidence and virtual care

Attendees will leave with practical insights into how and why they should be partnering with the NHS to improve patient outcomes in the wake of this global pandemic.

About the panel

Debra Mitchell is deputy chief operating officer - Leicester, Leicestershire and Rutland Integrated Care Board (LLR ICB)

Debra joined LLR ICB last year to lead the development of Rutland as a Place along with a Long Term Conditions Transformation Programme. Having joined the NHS as a National Management Trainee in 1989 straight from Nottingham University, Debra has over 30 years’ experience in NHS Management mainly in the Acute sector and was Acting Chief Operating Officer for Leicester Hospital throughout the 2 years of the COVID Pandemic. During her career, Debra has managed the vast majority of Clinical Services within Acute Hospitals spanning 3 Health Regions. She spent 2 years leading a transformation and Cost Improvement programme and also led the development of an Elective Care Alliance comprising of 3 Provider and 2 Commissioning Organisations.

Stephen Jowett is senior director & head of healthcare consulting IQVIA

Stephen leads IQVIA’s Market Access, Pathway Transformation and Pathway Analytics teams with a focus on enabling successful collaboration between the NHS and the life sciences industry. Stephen has worked extensively within innovation and digital enablement in healthcare, strategy consulting and service re-design for over fifteen years. Early in Stephen’s career, he got to see first-hand how the successful alignment of people, process and technology could drastically improve care quality and patient outcomes via his work on the adoption of electronic medical record technology at the front line of care. Subsequently, at IQVIA Stephen has sought to harness the use of real-world data to inform patient centric service models, making certain that patient’s receive equitable access to the care they deserve.

Dr Véronique Walsh is general manager & vice-president, Gilead – UK & Ireland

Véronique joined Gilead in October 2021 as general manager & VP for the UK & Ireland. Previously she worked at Bristol-Myers Squibb (BMS), where she spent the last two years as General Manager for Benelux, building on 25 years of experience in the pharmaceutical industry. Prior to this experience, Véronique held leadership positions for the UK & Ireland affiliate at BMS, including interim General Manager, and Business Unit Director for the Innovative Medicines franchise and Virology, where she was responsible for their HIV, Hepatitis B, and Hepatitis C portfolio. Before joining BMS, Véronique held commercial roles at Sanofi Pasteur MSD and Aventis Pasteur MSD in the UK and France. Véronique is a Medical Doctor by training.

Jim McArdle is Senior Director, Strategy & Business Development, Interface Clinical Services, IQVIA

After qualifying as a pharmacist, Jim worked across many sectors of pharmacy both in the UK and internationally. In 2006, Jim joined Interface Clinical Services as Commercial Director, responsible for strategy and growth, and was a key factor in the success of the organisation. A passionate proponent of the role of clinical pharmacists, harnessing data to inform clinical and commissioning decisions, and patient centricity, Jim is viewed as a true innovator in healthcare. He has led on many projects designed to improve the lives and wellbeing of patients across primary and secondary care and recognises the value in collaborative working between the NHS and life science sector, to bring innovative solutions to health economies and to patients. Jim has a BSc in Pharmacy from LJMU and a Masters in Business Administration (MBA) from the University of Liverpool

Dr Paul Tunnah is managing director Healthware International (moderator)

Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. Dr Tunnah also holds a BA in Biochemistry and DPhil in Biological Sciences from Oxford University, where his work focused on identification of novel anticancer therapies.